← Human Trials & Peer-Reviewed Studies
The effect of vitamin D on renin-angiotensin system activation and blood pressure: a randomized control trial.
Plain-language guide to PMID 28033130 (2017): double-blind randomized controlled trial of Vitamin D, K2, Magnesium and Zinc, low blood pressure and orthostatic hypotension.
Key Facts
- PMID
- 28033130
- Journal
- Journal of hypertension
- Year
- 2017
- Study type
- Randomized Controlled Trial
- Authors
- McMullan CJ et al. (5 authors)
- DOI
- 10.1097/HJH.0000000000001220
What This Study Did, in Plain Language
What Was Tested
The paper reports a study of Vitamin D, K2, Magnesium and Zinc in the context of low blood pressure and orthostatic hypotension, published as a randomized controlled trial.
Disruption of vitamin D signaling in rodents causes activation of the rennin-angiotensin system (RAS) and development of hypertension.
The researchers performed the first randomized control trial to investigate the effects of vitamin D supplementation on the RAS in humans.
Who Took Part
PubMed indexes the participants as young adults, adults and middle-aged adults, both men and women.
How the Study Was Run
The researchers set it up as a randomized, double-blind and placebo-controlled study.
The participants were allocated by chance, so the Vitamin D, K2, Magnesium and Zinc group and the comparison group should start out alike.
Neither the participants nor the staff measuring them knew who was on Vitamin D, K2, Magnesium and Zinc, so expectations could not easily colour the readings.
The comparison arm used a placebo, so changes seen with Vitamin D, K2, Magnesium and Zinc could be set against what happens without it.
Kidney-specific RAS activity, measured using renal plasma flow response to captopril in high sodium balance, was assessed at baseline and 8 weeks, as was systemic RAS activity and 24-h ambulatory BP.
What Was Measured
Topics PubMed links to this paper include Antihypertensive Agents, Blood Pressure, Blood Pressure Determination, Captopril, Dietary Supplements, Ergocalciferols and Overweight.
What This Means in Plain Language
The paper is a randomized, double-blind and placebo-controlled study of Vitamin D, K2, Magnesium and Zinc in people with low blood pressure and orthostatic hypotension.
The abstract goes on to report its results in about 6 sentences; this page does not restate them, so read the paper for the findings and their limits.
The publication is from 2017 (Journal of hypertension), a journal based in Netherlands.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, Low blood pressure and orthostatic hypotension research.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
- Low blood pressure and orthostatic hypotension research
- Vitamin D, K2, Magnesium and Zinc in the library
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.